Phase I/II trial of oral masofaniten (EPI-7386) in combination with enzalutamide (Enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects Meeting Abstract
| Authors: | Kyriakopoulos, C.; Chatta, G.; Laccetti, A. L.; Iannotti, N.; Sokolova, A. O.; Hotte, S. J.; Tutrone, R.; Markowski, M. C.; Nordquist, L. T.; Pili, R.; Saad, F.; Zhang, J.; Villaluna, K.; Younginger, B.; Le Moigne, R.; Cesano, A. |
| Abstract Title: | Phase I/II trial of oral masofaniten (EPI-7386) in combination with enzalutamide (Enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S990 |
| Language: | English |
| ACCESSION: | WOS:001326612902263 |
| DOI: | 10.1016/j.annonc.2024.08.1722 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1641P -- Source: Wos |
